Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 5—May 2004

Enzyme-Linked Immunosorbent Assay and Serologic Responses to Pneumocystis jiroveci

Kieran R. Daly*Comments to Author , Judy Koch*, Linda Levin*, and Peter D. Walzer*
Author affiliations: *University of Cincinnati College of Medicine, Cincinnati, Ohio, USA; ‡Veterans Affairs Medical Center, Cincinnati, Ohio, USA

Main Article

Table 3

Adjusted odds ratios (95% CI) measuring the associations between Western blot reactivity and participant status (blood donor versus PCP-positive, PCP-negative, HIV) among 189 study participantsa,b

ELISA Midpoint Blood donor: PCP+ (95% CI) Blood donor: PCP– (95% CI) Blood donor: HIV (95% CI)
3.2 (1.6 to 6.7)
2.2 (1.4 to 3.5)
2.7 (1.7 to 4.3)
5.9 (2.5 to 14.3)
3.2 (2.0 to 5.3)
4.3 (2.6 to 7.4)
3 35 10.0 (2.9 to 33.3) 9.1 (4.4 to 20.0) 9.4 (4.6 to 19.3)

aCI, confidence interval; ELISA, enzyme-linked immunosorbent assay; PCP, Pneumocystis pneumonia.
bOdds ratios measuring the association between Western blot reactivity and participant status were calculated at the midpoints of ELISA measurements over all antigens. Based on 95% confidence intervals, blood donors had significantly increased odds of Western blot reactivity compared to each patient group (p < 0.05) for each ELISA.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.